NURS: A 50-state B2B healthcare platform scales on license growth and peptide-regulatory tailwinds
A modular, 50-state B2B healthcare platform is scaling rapidly: Q2 revenue was $28 million, up 420% YoY, and third-vertical licensees exceeded 11,000 by March-April 2026.…
TR
By Tom Reyes · Markets Editor
Oct 28 09:22 ETSource: TradingView
From the source
Read at tradingview.comNURS: A 50-state B2B healthcare platform scales on license growth and peptide-regulatory tailwinds
A modular, 50-state B2B healthcare platform is scaling rapidly: Q2 revenue was $28 million, up 420% YoY, and third-vertical licensees exceeded 11,000 by March-April 2026. Management sees peptide regulation and new treatments as growth catalysts through 2027 and beyond.
